The new mantra is getting LDL cholesterol levels lower than statin drugs. The drug class of these new cholesterol-lowering drugs is a PCSK9 inhibitor.
Of course, this is madness for two reasons: (1) Cholesterol and fats, in general, are not the cause of heart disease; (2) cholesterol is vital for hormone production and nervous system and brain function.
So why the focus for a new cholesterol-lowering drug? Are drug companies finally getting real feedback on side effects?
Well, statistically around 15 percent of statin patients are considered statin intolerant. It might be safe to assume any side effects reported were not considered caused by lowering cholesterol, the drug’s primary function.
The fact is that cholesterol is vitally essential for good health, and lowering cholesterol artificially can and does lead to more immediate health problems, and a lower life expectancy. (See: Statin Scam: People with Higher Cholesterol Live Longer than People with Low Cholesterol)
Heart attacks still remain high since statins have been issued for anyone with heart problems or anyone that may have what are considered, albeit often falsely, markers predicting heart problems. The results have been disastrous. (Source)
One would hope the medical system would realize that lowering cholesterol is not a good thing because it is vital for many of our hormonal activity and brain and nervous system structure. Despite occasional dissenting voices from within, the medical industry and its drug cartel are not going to realize that.
No comments:
Post a Comment